Literature DB >> 2271398

Changes in sodium-lithium countertransport correlate with changes in triglyceride levels and body mass index over 2 1/2 years of follow-up in Utah.

S C Hunt1, R R Williams, K O Ash.   

Abstract

We have previously reported from a cross-sectional study that plasma total cholesterol, triglycerides, and HDL-C were significantly and independently correlated with Na(+)-Li+ countertransport. These original participants were rescreened 2 1/2 years later (range of 20-58 months), with lipid, blood pressure, and Na(+)-Li+ countertransport measurements from both visits on 906 normotensive adults. The correlation found between age- and sex-adjusted triglyceride levels and Na(+)-Li+ countertransport at visit 1 (r = 0.34, p less than 0.0001) was reconfirmed at visit 2 (r = 0.32, p less than 0.0001). The Na(+)-Li+ countertransport correlations with HDL-C (r = -0.11, p less than 0.01) and body mass index (r = 0.24, p less than 0.0001) also remained at visit 2. After 30 months, there were significant increases of triglyceride, body mass index, blood pressure, and Na(+)-Li+ countertransport levels, and significant decreases of HDL-C and total cholesterol levels, after adjusting the changes in these variables between visit 2 and visit 1 for age, sex, time between the two visits, and the visit 1 level of the variable. Increases in triglycerides, cholesterol, and body mass index were significantly correlated with increases in Na(+)-Li+ countertransport (r = 0.23, r = 0.19, and r = 0.21, respectively). The correlations of the lipid and lipoprotein changes with Na(+)-Li+ countertransport changes were independent of body mass index and blood pressure changes. We conclude that increasing plasma triglyceride levels and body mass index are associated with increasing Na(+)-Li+ countertransport levels in both cross-sectional and longitudinal data.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2271398     DOI: 10.1007/bf02603176

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  28 in total

1.  Changes in erythrocyte sodium and plasma lipids associated with physical training.

Authors:  P Hespel; P Lijnen; R Fagard; J R M'Buyamba-Kabangu; R Van Hoof; W Lissens; M Rosseneu; A Amery
Journal:  J Hypertens       Date:  1988-02       Impact factor: 4.844

2.  Dietary changes in membrane lipids and leucocyte calcium.

Authors:  R F Bing; A M Heagerty; J D Swales
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

3.  Prevalence of cardiovascular disease risk factors in blacks and whites: the Minnesota Heart Survey.

Authors:  J M Sprafka; A R Folsom; G L Burke; S A Edlavitch
Journal:  Am J Public Health       Date:  1988-12       Impact factor: 9.308

4.  Hypertension and sodium-lithium countertransport in Utah pedigrees: evidence for major-locus inheritance.

Authors:  S J Hasstedt; L L Wu; K O Ash; H Kuida; R R Williams
Journal:  Am J Hum Genet       Date:  1988-07       Impact factor: 11.025

5.  Associations of three erythrocyte cation transport systems with plasma lipids in Utah subjects.

Authors:  S C Hunt; R R Williams; J B Smith; K O Ash
Journal:  Hypertension       Date:  1986-01       Impact factor: 10.190

6.  Low-density lipoprotein subclass patterns and risk of myocardial infarction.

Authors:  M A Austin; J L Breslow; C H Hennekens; J E Buring; W C Willett; R M Krauss
Journal:  JAMA       Date:  1988-10-07       Impact factor: 56.272

7.  Abnormal red blood cell ion transport and hypertension. The People's Gas Company study.

Authors:  M Trevisan; D Ostrow; R Cooper; K Liu; S Sparks; A Okonek; E Stevens; J Marquardt; J Stamler
Journal:  Hypertension       Date:  1983 May-Jun       Impact factor: 10.190

8.  Recruitment of members of high-risk Utah pedigrees.

Authors:  R R Williams; S C Hunt
Journal:  Control Clin Trials       Date:  1987-12

9.  Abnormalities of erythrocyte membrane fatty acid composition in human essential hypertension.

Authors:  J D Ollerenshaw; A M Heagerty; R F Bing; J D Swales
Journal:  J Hum Hypertens       Date:  1987-06       Impact factor: 3.012

10.  Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.

Authors:  S C Hunt; L L Wu; P N Hopkins; B M Stults; H Kuida; M E Ramirez; J M Lalouel; R R Williams
Journal:  Arteriosclerosis       Date:  1989 May-Jun
View more
  1 in total

Review 1.  Alterations in sodium metabolism as an etiological model for hypertension.

Authors:  P Lijnen
Journal:  Cardiovasc Drugs Ther       Date:  1995-06       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.